A Double-Blind, Randomized, Placebo-Controlled, Single-Dose Crossover Study to Assess the Safety and Tolerability of MK0893 Coadministered With Propranolol Hydrochloride in Patients With Type 2 Diabetes
Phase of Trial: Phase I
Latest Information Update: 12 Mar 2015
At a glance
- Drugs MK 0893 (Primary) ; Propranolol
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Merck Sharp & Dohme
- 05 Jul 2011 Actual patient number added.
- 02 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Dec 2009 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov.